Cargando…
Activated matriptase as a target to treat breast cancer with a drug conjugate
The antitumor effects of a novel antibody drug conjugate (ADC) was tested against human solid tumor cell lines and against human triple negative breast cancer (TNBC) xenografts in immunosuppressed mice. The ADC targeting activated matriptase of tumor cells was synthesized by using the potent anti-tu...
Autores principales: | Rather, Gulam M., Lin, Siang-Yo, Lin, Hongxia, Banach-Petrosky, Whitney, Hirshfield, Kim M., Lin, Chen-Yong, Johnson, Michael D., Szekely, Zoltan, Bertino, Joseph R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995259/ https://www.ncbi.nlm.nih.gov/pubmed/29899836 http://dx.doi.org/10.18632/oncotarget.25414 |
Ejemplares similares
-
A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma
por: Rather, Gulam M., et al.
Publicado: (2019) -
Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic Separation and Multi-frequency Impedance Cytometry for Targeted Therapy
por: Lin, Zhongtian, et al.
Publicado: (2020) -
Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or Cisplatin
por: Rather, Gulam Mohmad, et al.
Publicado: (2021) -
Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity
por: Tseng, Chun-Che, et al.
Publicado: (2017) -
Toward point-of-care assessment of patient response: a portable tool for rapidly assessing cancer drug efficacy using multifrequency impedance cytometry and supervised machine learning
por: Ahuja, Karan, et al.
Publicado: (2019)